Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 8 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 8 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

FDA Clears Stem Cell Trial for Multiple Sclerosis

neurons

The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis. . . . → Read More: FDA Clears Stem Cell Trial for Multiple Sclerosis

ALS Drug Maker Gains $135M in New Funds

Man in wheelchair

A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds

Pooled Saliva Tests Detect Covid-19 in Schools

Preparing classrooms for students return

Combining commercial saliva tests to speed detection of the SARS-CoV-2 virus in schools is shown as accurate as individual gold-standard nasal swab tests. . . . → Read More: Pooled Saliva Tests Detect Covid-19 in Schools

Trial to Test Antibody Drug for Alzheimer’s Prevention

Neurons

Eli Lilly and Company is partnering with an Alzheimer’s disease research center to test a synthetic antibody for preventing the disorder in at-risk individuals. . . . → Read More: Trial to Test Antibody Drug for Alzheimer’s Prevention

Immune Cell Cancer Biotech Gains $172M in New Funds

Natural killer cell

A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round. . . . → Read More: Immune Cell Cancer Biotech Gains $172M in New Funds

Trial Underway for Crispr Lymphoma Therapy

Crispr-Cas9

A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr. . . . → Read More: Trial Underway for Crispr Lymphoma Therapy

Fitness Tracker Data Show Longer Covid-19 Effects

Apple Watch and iPhone

Data collected from wearable activity trackers show extended cardiac effects in people with Covid-19 infections, in some cases for several months. . . . → Read More: Fitness Tracker Data Show Longer Covid-19 Effects

Univ. Lab Testing Wearable Respiratory Monitor

ADAMM device

Medical researchers are assessing the feasibility of a wearable device to detect advance indicators of chronic respiratory disease symptoms. . . . → Read More: Univ. Lab Testing Wearable Respiratory Monitor

Trial Underway Testing Suicide-Prevention Nasal Spray

Sad, depressed

A clinical trial testing a nasal spray against a placebo to prevent suicide from depression enrolled its first participants considered at high risk of suicide. . . . → Read More: Trial Underway Testing Suicide-Prevention Nasal Spray

GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal

Brain activity graphic

GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders. . . . → Read More: GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal